8-KMaterial AgreementsOther EventsExhibits & Filings

CVS HEALTH Corp 8-K Report, Material Agreement (Aug 13, 2008)

Filed August 13, 2008For Securities:CVS

Summary

CVS Health Corp. (CVS) announced a significant development with the entry into a definitive Agreement and Plan of Merger with Longs Drug Stores Corporation. This filing details a tender offer by CVS's subsidiary, Blue MergerSub Corp., to acquire all outstanding shares of Longs Drug Stores for $71.50 per share in cash. Following a successful tender offer, a merger will take place, making Longs a wholly owned subsidiary of CVS. This strategic move aims to expand CVS's retail pharmacy footprint and market presence. The transaction is not subject to a financing condition, which is positive for deal certainty. However, it is contingent on customary closing conditions, including antitrust approvals (Hart-Scott-Rodino) and a minimum tender condition requiring at least two-thirds of Longs' outstanding shares to be tendered. CVS has also secured an option to purchase additional Longs shares under certain conditions to facilitate a potential short-form merger. The agreement includes provisions for termination fees and restrictive covenants for Longs regarding unsolicited takeover proposals, signaling a strong commitment from both parties to complete the transaction.

Key Highlights

  • 1CVS Health (CVS) enters into a definitive Agreement and Plan of Merger with Longs Drug Stores Corporation.
  • 2CVS's subsidiary will commence a tender offer to acquire all Longs Drug Stores shares at $71.50 per share in cash.
  • 3The acquisition aims to integrate Longs Drug Stores into CVS's operations, expanding its retail pharmacy network.
  • 4The offer is not contingent on financing, reducing a key risk for deal completion.
  • 5Key closing conditions include antitrust approval (Hart-Scott-Rodino) and a minimum tender threshold of two-thirds of Longs' outstanding shares.
  • 6CVS has obtained an option to acquire additional Longs shares to potentially enable a short-form merger.
  • 7Longs is restricted from soliciting or engaging with competing takeover proposals, subject to certain exceptions.

Frequently Asked Questions

This 8-K filing announces that CVS Health has entered into a definitive merger agreement with Longs Drug Stores Corporation. It details the terms of a tender offer by a CVS subsidiary to acquire all outstanding shares of Longs Drug Stores for $71.50 per share in cash, with the ultimate goal of merging the two companies.

CVS Health is offering to purchase all outstanding shares of Longs Drug Stores for $71.50 per share in cash, without interest.

Yes, the acquisition is subject to several conditions, including the expiration of waiting periods under the Hart-Scott-Rodino Antitrust Improvement Act and a minimum tender condition requiring at least two-thirds of Longs' outstanding shares to be validly tendered and not withdrawn. Other customary closing conditions also apply.

The merger agreement includes a minimum tender condition where at least two-thirds of Longs' outstanding shares must be tendered for the offer to proceed. If this condition is not met, and not waived (which requires Longs' consent), the tender offer may not be completed.